Acetyl-d-carnitine

Acetyl-d-carnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2875 references associated with Acetyl-d-carnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Acetyl-d-carnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Acetyl-d-carnitine

MeSH term MeSH ID Detail
Proteostasis Deficiencies D057165 5 associated lipids
Parkinson Disease D010300 53 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cleft Lip D002971 8 associated lipids
Body Weight D001835 333 associated lipids
Amino Acid Metabolism, Inborn Errors D000592 16 associated lipids
Alzheimer Disease D000544 76 associated lipids
Total 7

All references with Acetyl-d-carnitine

Download all related citations
Per page 10 20 50 100 | Total 877
Authors Title Published Journal PubMed Link
Ori C et al. Effects of acetyl-L-carnitine on regional cerebral glucose metabolism in awake rats. 2002 Brain Res. pmid:12270513
Sharman EH et al. Reversal of biochemical and behavioral parameters of brain aging by melatonin and acetyl L-carnitine. 2002 Brain Res. pmid:12445964
Roberts PA et al. The temporal relationship between glycogen phosphorylase and activation of the pyruvate dehydrogenase complex during adrenaline infusion in resting canine skeletal muscle. 2002 J. Physiol. (Lond.) pmid:12433969
Tolu P et al. Effects of long-term acetyl-L-carnitine administration in rats: I. increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure. 2002 Neuropsychopharmacology pmid:12225698
Pop-Busui R et al. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. 2002 Diabetes pmid:12145179
Graziano F et al. Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. 2002 Br. J. Cancer pmid:12085175
Chiechio S et al. L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. 2002 Mol. Pharmacol. pmid:11961116
Iossa S et al. Acetyl-L-carnitine supplementation differently influences nutrient partitioning, serum leptin concentration and skeletal muscle mitochondrial respiration in young and old rats. 2002 J. Nutr. pmid:11925454
Liu J et al. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. 2002 Ann. N. Y. Acad. Sci. pmid:11976193
Hagen TM et al. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. 2002 Ann. N. Y. Acad. Sci. pmid:11976222
Watt MJ et al. Carbohydrate ingestion reduces skeletal muscle acetylcarnitine availability but has no effect on substrate phosphorylation at the onset of exercise in man. 2002 J. Physiol. (Lond.) pmid:12411537
Watt MJ et al. Intramuscular triacylglycerol, glycogen and acetyl group metabolism during 4 h of moderate exercise in man. 2002 J. Physiol. (Lond.) pmid:12068055
Tyni T et al. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle. 2002 Pediatr. Res. pmid:12084849
Defani MA et al. Effect of acetyl-L-carnitine on VIP-ergic neurons in the jejunum submucous plexus of diabetic rats. 2003 Arq Neuropsiquiatr pmid:14762599
Pisano C et al. Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. 2003 Clin. Cancer Res. pmid:14654561
Pascale E et al. Modulation of methylation in the FMR1 promoter region after long term treatment with L-carnitine and acetyl-L-carnitine. 2003 J. Med. Genet. pmid:12807975
Masi F et al. Effects of long-term acetyl-L-carnitine administration in rats--II: Protection against the disrupting effect of stress on the acquisition of appetitive behavior. 2003 Neuropsychopharmacology pmid:12655313
Mattei B et al. Pharmacologically induced enhancement of recurrent inhibition in humans: effects on motoneurone discharge patterns. 2003 J. Physiol. (Lond.) pmid:12611926
Arafa HM and Sayed-Ahmed MM Protective role of carnitine esters against alcohol-induced gastric lesions in rats. 2003 Pharmacol. Res. pmid:12860448
Cui J et al. Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts. 2003 Mol. Cell. Biochem. pmid:14674702
Beal MF Bioenergetic approaches for neuroprotection in Parkinson's disease. 2003 Ann. Neurol. pmid:12666097
Feher J et al. Mitotropic compounds for the treatment of age-related macular degeneration. The metabolic approach and a pilot study. 2003 Sep-Oct Ophthalmologica pmid:12913326
Evans AM et al. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. 2004 Kidney Int. pmid:15458447
Leblanc PJ et al. Effects of 7 wk of endurance training on human skeletal muscle metabolism during submaximal exercise. 2004 J. Appl. Physiol. pmid:15220302
Tanaka Y et al. Acetyl-L-carnitine supplementation restores decreased tissue carnitine levels and impaired lipid metabolism in aged rats. 2004 J. Lipid Res. pmid:14703509
Ames BN and Liu J Delaying the mitochondrial decay of aging with acetylcarnitine. 2004 Ann. N. Y. Acad. Sci. pmid:15591008
Bastianetto S and Quirion R Natural antioxidants and neurodegenerative diseases. 2004 Front. Biosci. pmid:15353369
Ames BN Delaying the mitochondrial decay of aging. 2004 Ann. N. Y. Acad. Sci. pmid:15247055
Vermeulen RC and Scholte HR Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome. 2004 Mar-Apr Psychosom Med pmid:15039515
Cavallini G et al. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. 2004 Sep-Oct J. Androl. pmid:15292108
Bianchi G et al. Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. 2005 Eur. J. Cancer pmid:16039110
Kobayashi D et al. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells. 2005 Reproduction pmid:16322553
Zanelli SA et al. Mechanisms of ischemic neuroprotection by acetyl-L-carnitine. 2005 Ann. N. Y. Acad. Sci. pmid:16179519
Pracharoenwattana I et al. Arabidopsis peroxisomal citrate synthase is required for fatty acid respiration and seed germination. 2005 Plant Cell pmid:15923350
Tabolacci E et al. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. 2005 Eur. J. Hum. Genet. pmid:15741991
Kasumov T et al. Probing peroxisomal beta-oxidation and the labelling of acetyl-CoA proxies with [1-(13C)]octanoate and [3-(13C)]octanoate in the perfused rat liver. 2005 Biochem. J. pmid:15773815
Bian F et al. Peroxisomal and mitochondrial oxidation of fatty acids in the heart, assessed from the 13C labeling of malonyl-CoA and the acetyl moiety of citrate. 2005 J. Biol. Chem. pmid:15611129
Roberts PA et al. Acetyl-CoA provision and the acetyl group deficit at the onset of contraction in ischemic canine skeletal muscle. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15454400
Peluso G et al. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells. 2005 J. Cell. Physiol. pmid:15515015
Cavallini G et al. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy. 2005 Urology pmid:16286128
Roepstorff C et al. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15383373
Szutowicz A et al. Nerve growth factor and acetyl-L-carnitine evoked shifts in acetyl-CoA and cholinergic SN56 cell vulnerability to neurotoxic inputs. 2005 Jan 1-15 J. Neurosci. Res. pmid:15558747
Ghirardi O et al. Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties. 2005 Jul-Aug Anticancer Res. pmid:16080512
Feher J et al. Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. 2005 May-Jun Ophthalmologica pmid:15947501
Ghirardi O et al. Chemotherapy-induced allodinia: neuroprotective effect of acetyl-L-carnitine. 2005 May-Jun In Vivo pmid:15875786
Ferraresi R et al. Protective effect of acetyl-L-carnitine against oxidative stress induced by antiretroviral drugs. 2006 FEBS Lett. pmid:17118360
Chiechio S et al. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine. 2006 Mol Pain pmid:16764720
Jensen MV et al. Compensatory responses to pyruvate carboxylase suppression in islet beta-cells. Preservation of glucose-stimulated insulin secretion. 2006 J. Biol. Chem. pmid:16740637
Gago MF et al. SANDO: two novel mutations in POLG1 gene. 2006 Neuromuscul. Disord. pmid:16919951
Hack A et al. Monitoring of ketogenic diet for carnitine metabolites by subcutaneous microdialysis. 2006 Pediatr. Res. pmid:16690958

Table of Content